Ning Zhang
- Cancer Research top 0.1%
- MicroRNA in disease regulation 68
- Cancer-related molecular mechanisms research 59
- Molecular Biology top 0.5%
- Circular RNAs in diseases 55
- RNA modifications and cancer 35
- Extracellular vesicles in disease 26
- Oncology top 1%
- Cancer Cells and Metastasis 20
- Pathology and Forensic Medicine top 0.5%
- Cancer Mechanisms and Therapy 24
- Immunology and Allergy top 1%
-
- Autophagy in Disease and Therapy 21
- Journals
- Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (1 paper)Nature Communications (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ning Zhang
541 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 5.0k
- Molecular Biology 7.9k
- Oncology 2.5k
- Pathology and Forensic Medicine 1.3k
- Immunology and Allergy 421
Countries citing papers authored by Ning Zhang
This map shows the geographic impact of Ning Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Zhang more than expected).
Fields of papers citing papers by Ning Zhang
This network shows the impact of papers produced by Ning Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Zhang. The network helps show where Ning Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ning Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 6 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 21 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 40 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 2 | |
| 13 | 2021 | 4 | |
| 14 | Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p | 2020 | 0 |
| 15 | microRNA-182 Negatively Influences the Neuroprotective Effect of Apelin Against Neuronal Injury in Epilepsy | 2020 | 0 |
| 16 | 2019 | 107 | |
| 17 | circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancerbreakdown → | 2019 | 340 |
| 18 | 2015 | 57 | |
| 19 | 2013 | 92 | |
| 20 | 2004 | 117 |
About Ning Zhang
Ning Zhang is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 564 papers that have together received 14.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (68 papers), Cancer-related molecular mechanisms research (59 papers), Circular RNAs in diseases (55 papers), RNA modifications and cancer (35 papers), Extracellular vesicles in disease (26 papers), Cancer Mechanisms and Therapy (24 papers), Autophagy in Disease and Therapy (21 papers) and Cancer Cells and Metastasis (20 papers). The work is most often cited by research in Cancer Research (5.0k citations), Molecular Biology (7.9k citations) and Oncology (2.5k citations). Ning Zhang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Qifeng Yang, Hanwen Zhang, Yaming Li, Bing Chen, Yiran Liang, Wenjing Zhao, Xiaolong Wang, Ying Liu, Qiang Huo and Yuting Sang. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.